![[생물공학개론] 바이오시밀러(Biosimilar)-1](http://images.happyhaksul.com/thumb/551/550301-0001.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-2](http://images.happyhaksul.com/thumb/551/550301-0002.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-3](http://images.happyhaksul.com/thumb/551/550301-0003.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-4](http://images.happyhaksul.com/thumb/551/550301-0004.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-5](http://images.happyhaksul.com/thumb/551/550301-0005.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-6](http://images.happyhaksul.com/thumb/551/550301-0006.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-7](http://images.happyhaksul.com/thumb/551/550301-0007.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-8](http://images.happyhaksul.com/thumb/551/550301-0008.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-9](http://images.happyhaksul.com/thumb/551/550301-0009.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-10](http://images.happyhaksul.com/thumb/551/550301-0010.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-11](http://images.happyhaksul.com/thumb/551/550301-0011.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-12](http://images.happyhaksul.com/thumb/551/550301-0012.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-13](http://images.happyhaksul.com/thumb/551/550301-0013.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-14](http://images.happyhaksul.com/thumb/551/550301-0014.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-15](http://images.happyhaksul.com/thumb/551/550301-0015.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-16](http://images.happyhaksul.com/thumb/551/550301-0016.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-17](http://images.happyhaksul.com/thumb/551/550301-0017.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-18](http://images.happyhaksul.com/thumb/551/550301-0018.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-19](http://images.happyhaksul.com/thumb/551/550301-0019.gif)
![[생물공학개론] 바이오시밀러(Biosimilar)-20](http://images.happyhaksul.com/thumb/551/550301-0020.gif)
분야
pptx2.바이오시밀러의 발전 배경 및 장점
3.바이오의약품 개념 및 특허동향
4.치료용 항체 의약품
5.유전자 재조합 의약품
6.전망
In vitro antibody libraries Transgenic mouse Human hybridomas
Genetic engineering V gene cloning CDR grafting Eukaryotic expression
2010년 4월 10일 헬스코리야뉴스
바이오산업-키움증권 투자 자료
미래산업전망대/ 삼성경제연구소 / p. 161~175
신성장동력산업 비즈니스전략Ⅱ 中 첨단융합산업편 / 첨단기술정보분석연구회/ p.73~81
http://blog.naver.com/battlehun?Redirect=Log&logNo=90107927860
㈜비아글로벌
http://blog.naver.com/jjylhw/80125212347
http://www.nature.com/news/
바이오시밀러 산업동향과 국내기업의 진입전략
http://www.bioin.or.kr/board.do?cmd=print&num=188901&bid=feature
